GGC Formulary
1. Gastro-intestinal system
1.1. Dyspepsia and gastro-oesophageal reflux disease
1.2. Antispasmodics and other drugs altering gut motility
1.3. Antisecretory drugs and mucosal protectants
1.4. Acute diarrhoea
1.5. Chronic bowel disorders
1.6. Laxatives
1.7. Local preparations for anal and rectal disorders
1.8. Stoma care
1.9. Drugs affecting intestinal secretions
2. Cardiovascular system
2.1. Positive inotropic drugs
2.2. Diuretics
2.3. Anti-arrhythmic drugs
2.4. Beta-adrenoceptor blocking drugs
2.5. Hypertension and heart failure
2.6. Nitrates, calcium-channel blockers and other antianginal drugs
2.7. Sympathomimetics
2.8. Anticoagulants and protamine
2.9. Antiplatelet drugs
2.10. Stable angina, acute coronary syndromes and fibrinolysis
2.11. Antifibrinolytic drugs and haemostatics
2.12. Lipid-modifying drugs
2.13. Local sclerosants
3. Respiratory system
3.1. Bronchodilators
3.2. Corticosteroids
3.3. Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inh
3.4. Antihistamines, hyposensitisation, and allergic emergencies
3.5. Respiratory stimulants and pulmonary surfactants
3.6. Oxygen
3.7. Mucolytics
3.8. Aromatic inhalations
3.9. Cough preparations
3.10. Systemic nasal decongestants
3.11. Antifibrotics
3.12. Cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies
4. Central nervous system
4.1. Hypnotics and anxiolytics
4.2. Drugs used in psychoses and related disorders
4.3. Antidepressant drugs
4.4. CNS stimulants and drugs used for attention deficit hyperactivity disorder
4.5. Drugs used in the treatment of obesity
4.6. Drugs used in nausea and vertigo
4.7. Analgesics
4.8. Antiepileptic drugs
4.9. Drugs used in parkinsonism and related disorders
4.10. Drugs used in substance dependence
4.11. Drugs for dementia
5. Infections
5.1. Antibacterial drugs
5.2. Antifungal drugs
5.3. Antiviral drugs
5.4. Antiprotozoal drugs
5.5. Anthelmintics
5.6. COVID-19 infection
6. Endocrine system
6.1. Drugs used in diabetes
6.2. Thyroid and antithyroid drugs
6.3. Corticosteroids
6.4. Sex hormones
6.5. Hypothalamic and pituitary hormones and anti-oestrogens
6.6. Drugs affecting bone metabolism
6.7. Other endocrine drugs
7. Obstetrics, gynaecology, renal and urinary-tract disorders
7.1. Drugs used in obstetrics
7.2. Treatment of vaginal and vulval conditions
7.3. Contraceptives
7.4. Drugs for genito-urinary disorders
7.5. Drugs used in Chronic Kidney Disease
8. Malignant disease and immunosuppression
8.1. Cytotoxic drugs
8.2. Drugs affecting the immune response
8.3. Sex hormones and hormone antagonists in malignant disease
9. Nutrition and blood
9.1. Anaemias and some other blood disorders
9.2. Fluids and electrolytes
9.3. Intravenous nutrition
9.4. Oral nutrition
9.5. Minerals
9.6. Vitamins
9.7. Bitters and tonics
9.8. Metabolic disorders
10. Musculoskeletal and joint diseases
10.1. Drugs used in rheumatic diseases and gout
10.2. Drugs used in neuromuscular disorders
10.3. Drugs for the relief of soft-tissue inflammation and topical pain relief
11. Eye
11.1. Administration of drugs to the eye
11.2. Control of microbial contamination
11.3. Anti-infective eye preparations
11.4. Corticosteroids and other anti-inflammatory preparations
11.5. Mydriatics and cycloplegics
11.6. Treatment of glaucoma
11.7. Local anaesthetics
11.8. Miscellaneous ophthalmic preparations
11.9. Contact lenses
12. Ear, nose and oropharynx
12.1. Drugs acting on the ear
12.2. Drugs acting on the nose
12.3. Drugs acting on the oropharynx
13. Skin
13.2. Emollient and barrier preparations
13.3. Local anaesthetics and antipruritics
13.4. Topical corticosteroids
13.5. Preparations for eczema and psoriasis
13.6. Acne and rosacea
13.7. Preparations for warts and calluses
13.8. Sunscreens, camouflagers and photodamage
13.9. Shampoos and other preparations for scalp and hair conditions
13.10. Anti-infective skin preparations
13.11. Skin cleansers, antiseptics, and preparations for promotion of wound healing
13.12. Antiperspirants
14. Immunological products and vaccines
14.5. Immunoglobulins
14.4. Vaccines and antisera
15. Anaesthesia
15.1. General anaesthesia
15.2. Local anaesthesia
16. Treatment of poisoning
16.1. Removal and elimination
16.2. Specific antidotes
Latest Formulary Decisions
Medicines Update Blogs
Latest Updates
Medicines Update
Medicines Update Extra
Adult Therapeutics Handbook
Clinical Guidelines
COVID-19 (Coronavirus)
Medicines Policies
Other Formularies
Paediatric Formulary
Pharmacy First
Non- medicines Formularies
Unscheduled Care Formulary
PACS, IPTR and ULM
Patient Information
Access to Medicines
Direct Oral Anticoagulants
Epilepsy
Gluten-Free (Patients)
Vitamin D
Unlicensed or off-label medicines
Medicinal Cannabis
Prescribing Resources
Shared Care Agreements
Supply Problems (StaffNet)
Contact Us
CMOP
CMOP Homepage
Publications
Meet the Team
Contact Us
Get Involved
NHS Greater Glasgow and Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
GGC Formulary
1. Gastro-intestinal system
1.1. Dyspepsia and gastro-oesophageal reflux disease
1.2. Antispasmodics and other drugs altering gut motility
1.3. Antisecretory drugs and mucosal protectants
1.4. Acute diarrhoea
1.5. Chronic bowel disorders
1.6. Laxatives
1.7. Local preparations for anal and rectal disorders
1.8. Stoma care
1.9. Drugs affecting intestinal secretions
2. Cardiovascular system
2.1. Positive inotropic drugs
2.2. Diuretics
2.3. Anti-arrhythmic drugs
2.4. Beta-adrenoceptor blocking drugs
2.5. Hypertension and heart failure
2.6. Nitrates, calcium-channel blockers and other antianginal drugs
2.7. Sympathomimetics
2.8. Anticoagulants and protamine
2.9. Antiplatelet drugs
2.10. Stable angina, acute coronary syndromes and fibrinolysis
2.11. Antifibrinolytic drugs and haemostatics
2.12. Lipid-modifying drugs
2.13. Local sclerosants
3. Respiratory system
3.1. Bronchodilators
3.2. Corticosteroids
3.3. Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inh
3.4. Antihistamines, hyposensitisation, and allergic emergencies
3.5. Respiratory stimulants and pulmonary surfactants
3.6. Oxygen
3.7. Mucolytics
3.8. Aromatic inhalations
3.9. Cough preparations
3.10. Systemic nasal decongestants
3.11. Antifibrotics
3.12. Cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies
4. Central nervous system
4.1. Hypnotics and anxiolytics
4.2. Drugs used in psychoses and related disorders
4.3. Antidepressant drugs
4.4. CNS stimulants and drugs used for attention deficit hyperactivity disorder
4.5. Drugs used in the treatment of obesity
4.6. Drugs used in nausea and vertigo
4.7. Analgesics
4.8. Antiepileptic drugs
4.9. Drugs used in parkinsonism and related disorders
4.10. Drugs used in substance dependence
4.11. Drugs for dementia
5. Infections
5.1. Antibacterial drugs
5.2. Antifungal drugs
5.3. Antiviral drugs
5.4. Antiprotozoal drugs
5.5. Anthelmintics
5.6. COVID-19 infection
6. Endocrine system
6.1. Drugs used in diabetes
6.2. Thyroid and antithyroid drugs
6.3. Corticosteroids
6.4. Sex hormones
6.5. Hypothalamic and pituitary hormones and anti-oestrogens
6.6. Drugs affecting bone metabolism
6.7. Other endocrine drugs
7. Obstetrics, gynaecology, renal and urinary-tract disorders
7.1. Drugs used in obstetrics
7.2. Treatment of vaginal and vulval conditions
7.3. Contraceptives
7.4. Drugs for genito-urinary disorders
7.5. Drugs used in Chronic Kidney Disease
8. Malignant disease and immunosuppression
8.1. Cytotoxic drugs
8.2. Drugs affecting the immune response
8.3. Sex hormones and hormone antagonists in malignant disease
9. Nutrition and blood
9.1. Anaemias and some other blood disorders
9.2. Fluids and electrolytes
9.3. Intravenous nutrition
9.4. Oral nutrition
9.5. Minerals
9.6. Vitamins
9.7. Bitters and tonics
9.8. Metabolic disorders
10. Musculoskeletal and joint diseases
10.1. Drugs used in rheumatic diseases and gout
10.2. Drugs used in neuromuscular disorders
10.3. Drugs for the relief of soft-tissue inflammation and topical pain relief
11. Eye
11.1. Administration of drugs to the eye
11.2. Control of microbial contamination
11.3. Anti-infective eye preparations
11.4. Corticosteroids and other anti-inflammatory preparations
11.5. Mydriatics and cycloplegics
11.6. Treatment of glaucoma
11.7. Local anaesthetics
11.8. Miscellaneous ophthalmic preparations
11.9. Contact lenses
12. Ear, nose and oropharynx
12.1. Drugs acting on the ear
12.2. Drugs acting on the nose
12.3. Drugs acting on the oropharynx
13. Skin
13.2. Emollient and barrier preparations
13.3. Local anaesthetics and antipruritics
13.4. Topical corticosteroids
13.5. Preparations for eczema and psoriasis
13.6. Acne and rosacea
13.7. Preparations for warts and calluses
13.8. Sunscreens, camouflagers and photodamage
13.9. Shampoos and other preparations for scalp and hair conditions
13.10. Anti-infective skin preparations
13.11. Skin cleansers, antiseptics, and preparations for promotion of wound healing
13.12. Antiperspirants
14. Immunological products and vaccines
14.5. Immunoglobulins
14.4. Vaccines and antisera
15. Anaesthesia
15.1. General anaesthesia
15.2. Local anaesthesia
16. Treatment of poisoning
16.1. Removal and elimination
16.2. Specific antidotes
Latest Formulary Decisions
Medicines Update Blogs
Latest Updates
Medicines Update
Medicines Update Extra
Adult Therapeutics Handbook
Clinical Guidelines
COVID-19 (Coronavirus)
Medicines Policies
Other Formularies
Paediatric Formulary
Pharmacy First
Non- medicines Formularies
Unscheduled Care Formulary
PACS, IPTR and ULM
Patient Information
Access to Medicines
Direct Oral Anticoagulants
Epilepsy
Gluten-Free (Patients)
Vitamin D
Unlicensed or off-label medicines
Medicinal Cannabis
Prescribing Resources
Shared Care Agreements
Supply Problems (StaffNet)
Contact Us
CMOP
CMOP Homepage
Publications
Meet the Team
Contact Us
Get Involved
Go
Go
MUE 09: Parkinson's Disease in Acute Care
Archived February 2022.
